As biologic formulation technologies and regulatory parameters rapidly evolve, which issues and opportunities should remain highest on your radar? With market activity posting double-digit growth, the biosimilars industry has now reached a critical inflection point. The healthcare sector is increasingly exploring patient self-administration options for the treatment of numerous conditions. Forward-thinking organizations—well aware of rising adoption—are beginning to boost R&D, consider new commercial innovations and reassess portfolio management strategies. Read our February 2023 ONdrugDelivery article for expert biosimilars insights from Iain Simpson, PhD, commercial director at Phillips-Medisize, and George Spooner, chief of staff at Oxford Medical Products.
View Product Pages, Blogs, and Other Resources
Our Aria smart autoinjector is a powerful, flexible, platform, designed for ease of use with a compact form and aligned to key emerging global trends:
- Shifting of healthcare out of hospitals
- Ready for the connected world
- More sustainable solutions
Advanced Medical Innovation, Design and Production
The future is rich with potential for medical technology — and a better, connected patient experience is at the center of it. Improving lives by bringing more advanced care closer to home is not only possible but emerging rapidly.
For decades, Phillips-Medisize, a Molex company, has been laser focused on contract design and manufacturing of products in highly regulated industries such as Pharmaceuticals, where precision, reliability and quality are critical.
Exact Sciences and Phillips-Medisize Collaborate to Fight Colorectal Cancer
Exact Sciences, a leader in cancer testing, developed a game-changing at-home colorectal cancer kit, but needed support to build the highest quality product. With decades of manufacturing innovation for healthcare and life sciences companies, Exact Sciences found a quality-first collaborator in Phillips-Medisize.
February 2023 ONdrugDelivery